DODO launches DIP-19 proposal to migrate DODO liquidity pool on Ethereum to DODOchain
According to ChainCatcher, the decentralized trading protocol DODO released the DIP-19 proposal on the community forum, proposing to close the DODO liquidity pool on the Ethereum network and completely migrate it to the DODOchain mainnet.
It is reported that the migration aims to better serve the trading needs of DODO holders on DODOchain, enhance the trading capabilities of DODO tokens and multi-chain assets, and bring more profit opportunities to DODO liquidity providers.
The DODO team said that after the migration, users can provide liquidity for the DODO pool on DODOchain and receive token incentives. Once the proposal is passed, the DODO team will migrate the DODO-USDT pool currently managed by a multi-signature address on Ethereum after the DODOchain mainnet goes online. Since its creation on September 29, 2020, the pool has generated a total transaction volume of more than US$600 million and accumulated more than US$1.91 million in fees.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly

XRP Ledger adds account control feature, enabling enterprises to manage assets offline.

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.